Learning Community: The Role of Anti-Obesity Medications in T2DM Management

Updated: 11/22/23

Watch the Recorded Talk
Presented November 17, 2023
Dina Griauzde, MD, MSc Assistant Professor, Department of Internal Medicine University of Michigan, VA Ann Arbor Healthcare System; Diplomate, American Board of Obesity Medicine; Research Director, Michigan Medicine Weight Navigation Program; Co-medical Director, Weight Management and Metabolic Health Program, VAAAHS
Objectives
  • Pathophysiologic link between obesity and T2DM
  • Mechanism of action, efficacy, and safety of incretin mimetics for the
    treatment of obesity
  • Role for older anti-obesity medications in patient-centered obesity treatment
  • Case examples
Download Dr. Griauzde's Presentation Slides

Tags: Created By MCT2D, Video, For Providers, VBR Learning

MCT2D Newsletter

Subscribe to the MCT2D Newsletter

Once per month we deliver news, updates, events, and more directly to you!

ccteam@mct2d.org